| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_106f98044fed642ad44f4e011fad2286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a13f77fb6053498fc061c6b9816c90d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc16dbaf626108f210fbbde488fe3fc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75889ac7558da0657cdf351e60ca16a |
| publicationDate |
2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7144728-B1 |
| titleOfInvention |
Method of inducing anergic T helper cells |
| abstract |
This invention also provides a method of generating antigen specific human suppressor CD8+CD28− T cells. This invention further provides a method of generating allopeptide antigen specific human suppressor CD8+CD28− T cells. Methods of tent for reduction of risk of rejection of allografts and xenografts and autoimmune diseases using the human suppressor CD8+CD28− T cells so produced are also provided, as are methods of preventing rejection and autoimmune diseases, and vaccines comprising the produced suppressor T cells. Methods of diagnosis to determine whether a level of immuno-suppressant therapy requires a reduction are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007041982-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9211321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008038260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9822161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10670603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401328-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8207110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011034675-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7777008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299016-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009274685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008311073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012269860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8901281-B2 |
| priorityDate |
1999-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |